Related Experiment Video
Updated: May 1, 2026

11:54
Microfluidic Platform with Multiplexed Electronic Detection for Spatial Tracking of Particles
Published on: March 13, 2017
8.7K
Drift-Compensated Real-Time Electronic Sensing Platform for Cardiac Markers' Intelligent Multiplex Detection in Whole
Beibei Lu1,2, Hua Huang3, Kuaifa Fang4
1State Key Laboratory of Resource Insects, College of Sericulture, Textile and Biomass Sciences, Southwest University, Chongqing 400715, China.
ACS Sensors
|April 30, 2026
Summary
A new electrochemical sensing chip enables rapid, sensitive detection of cardiac markers in whole blood for early acute myocardial infarction (AMI) diagnosis at home. This point-of-care system simplifies testing and provides accurate results quickly.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Analytical Chemistry
Background:
- Accurate early diagnosis of acute myocardial infarction (AMI) is crucial but hindered by complex, lab-based conventional methods.
- Point-of-care testing (POCT) requires rapid, sensitive, and user-friendly diagnostic tools for decentralized applications like home use.
Purpose of the Study:
- To develop an electrochemical sensing integrated chip (Sensing IC) for rapid, sensitive, and accurate detection of cardiac markers.
- To create a smartphone-compatible system for home-based, real-time diagnosis of AMI.
Main Methods:
- An electrochemical Sensing IC utilizing AuNPs/MXene electrodes with a dual-signal drift-correction mechanism and dual-reporter system was developed.
- The Sensing IC was coupled with a smartphone-based portable analyzer for multiplex detection in whole blood.
- Dual redox reporters were employed to minimize signal drift and enable in situ calibration.
Main Results:
- The Sensing IC achieved picomolar limit of detection, demonstrating exceptional sensitivity.
- The smartphone-based system enabled real-time, high-sensitivity multiplex detection of cardiac markers directly in whole blood.
- The developed POCT system showed comparable accuracy to standard assays, reducing detection time by ~90% and simplifying sample preprocessing.
Conclusions:
- The developed Sensing IC platform facilitates early AMI diagnosis and timely clinical warnings.
- This intelligent, home-based cardiovascular monitoring system meets the demand for rapid, decentralized diagnostics.
- The technology holds significant potential for improving patient outcomes through accessible and efficient cardiac marker detection.

